Blueprint Medicines Corp (BPMC)
107.05
+0.05
(+0.05%)
USD |
NASDAQ |
May 03, 11:43
Blueprint Medicines 1 Year Total Returns (Daily): 114.5% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 114.5% |
| May 01, 2024 | 84.19% |
| April 30, 2024 | 78.92% |
| April 29, 2024 | 82.37% |
| April 26, 2024 | 89.72% |
| April 25, 2024 | 85.73% |
| April 24, 2024 | 92.01% |
| April 23, 2024 | 88.15% |
| April 22, 2024 | 84.73% |
| April 19, 2024 | 79.22% |
| April 18, 2024 | 81.58% |
| April 17, 2024 | 83.10% |
| April 16, 2024 | 83.72% |
| April 15, 2024 | 81.78% |
| April 12, 2024 | 99.20% |
| April 11, 2024 | 108.8% |
| April 10, 2024 | 113.5% |
| April 09, 2024 | 110.4% |
| April 08, 2024 | 108.9% |
| April 05, 2024 | 116.2% |
| April 04, 2024 | 114.9% |
| April 03, 2024 | 107.2% |
| April 02, 2024 | 103.5% |
| April 01, 2024 | 114.3% |
| March 28, 2024 | 122.8% |
| Date | Value |
|---|---|
| March 27, 2024 | 118.8% |
| March 26, 2024 | 106.2% |
| March 25, 2024 | 102.9% |
| March 22, 2024 | 100.0% |
| March 21, 2024 | 97.83% |
| March 20, 2024 | 94.79% |
| March 19, 2024 | 95.10% |
| March 18, 2024 | 92.55% |
| March 15, 2024 | 100.4% |
| March 14, 2024 | 89.19% |
| March 13, 2024 | 106.8% |
| March 12, 2024 | 113.6% |
| March 11, 2024 | 113.0% |
| March 08, 2024 | 110.3% |
| March 07, 2024 | 107.2% |
| March 06, 2024 | 108.2% |
| March 05, 2024 | 88.98% |
| March 04, 2024 | 91.36% |
| March 01, 2024 | 120.4% |
| February 29, 2024 | 120.7% |
| February 28, 2024 | 125.3% |
| February 27, 2024 | 146.3% |
| February 26, 2024 | 150.3% |
| February 23, 2024 | 115.3% |
| February 22, 2024 | 100.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.28%
Minimum
Nov 09 2022
150.3%
Maximum
Feb 26 2024
6.91%
Average
-0.05%
Median
Sep 18 2020
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals Inc | -24.47% |
| Apellis Pharmaceuticals Inc | -42.88% |
| Ionis Pharmaceuticals Inc | 21.34% |
| Madrigal Pharmaceuticals Inc | -28.68% |
| Sarepta Therapeutics Inc | 5.57% |